[Federal Register: March 10, 1999 (Volume 64, Number 46)]
[Notices]               
[Page 11924]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10mr99-103]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Flexibility System to Advance Innovative Research for Cancer 
Drug Discovery by Small Businesses.
    Date: April 8-10, 1999.
    Time: 7:00 p.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ramada Inn, 1775 Rockville Pike, Rockville, MD 20852.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6130 Executive Boulevard/EPN--Room 630D, Rockville, MD 
20892-7405, 301/496-7987.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 3, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5919 Filed 3-9-99; 8:45 am]
BILLING CODE 4140-01-M